Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
Regulatory decision-making depends on evidence that reflects how medical products perform in...
When two federal agencies, the National Center for Science and Engineering Statistics (NCSES) and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically, w...